Progressive Supranuclear Palsy-Corticobasal Syndrome (PSP-CBS)
This patient has Progressive Supranuclear Palsy with Corticobasal Syndrome phenotype (PSP-CBS), representing an overlap syndrome where PSP pathology manifests with prominent cortical features typically associated with corticobasal degeneration.
Diagnostic Reasoning
This 68-year-old patient presents with a constellation of features that straddle two atypical parkinsonian syndromes, but the underlying pathology is most likely PSP based on the imaging findings and clinical trajectory.
Key Clinical Features Supporting PSP:
- Early postural instability with backward falls – This is the hallmark of PSP, typically appearing in the sixth or seventh decade with a lurching gait and axial dystonia manifested as unexplained falls 1
- Vertical gaze palsy (downgaze) – The classic finding of vertical supranuclear gaze palsy, though it usually appears later in disease course 1
- Axial rigidity and bradykinesia – Core parkinsonian features seen in PSP 1
- Executive dysfunction – Consistent with frontal lobe involvement in PSP 1
Key Clinical Features Supporting Cortical Involvement (CBS phenotype):
- Asymmetric limb stiffness – Corticobasal degeneration typically presents with asymmetric limb clumsiness in patients between 50-70 years of age 1
- Apraxia – A cortical feature characteristic of CBD 1
- Alien-limb phenomenon – Pathognomonic for corticobasal syndrome, involving unilateral limb rigidity and dystonia 1
Imaging Findings Definitively Point to PSP:
The MRI findings are diagnostic for PSP pathology:
- Midbrain atrophy with hummingbird sign – This is the characteristic imaging finding of PSP, showing marked midbrain tegmental atrophy 2, 3, 4
- Asymmetric parietal-occipital cortical atrophy – While cortical atrophy can occur in PSP, the asymmetric pattern explains the CBS clinical phenotype 2
Understanding the Overlap Syndrome
PSP and CBD are both tauopathies where tau proteins abnormally accumulate in different brain regions 1. The clinical presentation can overlap significantly, and pathological studies have shown that patients with clinical features of CBD may have PSP pathology at autopsy 2, 5.
Critical diagnostic principle: When imaging shows the hummingbird sign with midbrain atrophy, the underlying pathology is PSP regardless of whether cortical features dominate the clinical picture 2, 4, 6.
Common Diagnostic Pitfall:
The presence of prominent cortical signs (apraxia, alien-limb phenomenon, asymmetric presentation) may lead clinicians to diagnose corticobasal degeneration. However, the hummingbird sign on MRI is specific for PSP pathology and should guide the diagnosis 2, 5. Historical case reports demonstrate that even when cortical atrophy is marked and cortical signs predominate, autopsy often confirms PSP rather than CBD pathology 2, 5.
Diagnostic Criteria Applied:
This patient meets criteria for probable PSP based on:
- Age of onset in late 60s (typical for PSP: mean age 63) 1
- Early postural instability with backward falls 1, 3
- Vertical supranuclear gaze palsy 1
- Axial rigidity predominating over limb rigidity 1
- Characteristic midbrain atrophy (hummingbird sign) on MRI 3, 4, 6
The cortical features (apraxia, alien-limb, asymmetry) represent the CBS phenotype of PSP rather than true corticobasal degeneration.
Clinical Implications:
- Poor levodopa response expected – PSP typically shows minimal to no response to dopaminergic therapy 7, 4
- Rapid progression anticipated – Mean disease duration approximately 6 years for atypical parkinsonisms 1
- High fall risk – Early and prominent postural instability requires aggressive fall prevention strategies 3, 6
- Multisystem involvement – Expect progressive dysphagia, dysarthria, and cognitive decline 2, 3
Final Diagnosis:
Progressive Supranuclear Palsy with Corticobasal Syndrome phenotype (PSP-CBS) – a recognized variant where PSP pathology presents with prominent asymmetric cortical signs alongside classic PSP features of early falls, vertical gaze palsy, and axial rigidity, confirmed by characteristic midbrain atrophy on imaging.